Catalent Pharma Solutions (Booth 1546) has appointed Sally Langa to the position of vice president, business development, for Catalent’s development and analytical services offerings. In this role, Ms. Langa will be responsible for growing Catalent’s early phase development business for small molecule compounds, including analytical services, formulation development and micronization. Ms. Langa joins Catalent from Halo Pharma where she held the role of vice president, sales and marketing. Her...